PROVIDER PROFILE · NPI 1447331087
Jonathan FeistmannMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,210
Unique beneficiaries
—
Total services
54,995
Distinct HCPCS
18
Medicare payment
$2.9M
Peer benchmark
Total Medicare services vs. 1,438 Ophthalmology providers in NY — top quintile (cohort median 1,869).
PRESCRIBING · PART D · 2024
Total Rx claims
481
Beneficiaries
—
Total drug cost
$32K
Distinct drugs
10
Brand share
14.8%
Top prescribed drugs
Latanoprost116 claims
Prednisolone Acetate98 claims
Bromfenac Sodium48 claims
Ofloxacin39 claims
Bromfenac Sodium37 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$9K
Payment records
41
By payment type
Consulting Fee$7K
Food and Beverage$2K
Travel and Lodging$791
Top paying entities
Consulting Fee$7K
Food and Beverage$2K
Travel and Lodging$791
REFERRAL NETWORK
Where Jonathan Feistmann's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 4 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| BETH ISRAEL MEDICAL CENTER | 31 | 136 |
| Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ | 18 | 55 |
| ST LUKES ROOSEVELT HOSPITAL CENTER | 14 | 85 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ | 11 | 20 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| BETH ISRAEL MEDICAL CENTER | 39 | 151 |
| Quest Diagnostics Incorporated Clinical Laboratory · Clifton, NJ | 20 | 41 |
| Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ | 17 | 32 |
| ST LUKES ROOSEVELT HOSPITAL CENTER | 13 | 48 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE